JP2022535102A5 - - Google Patents
Info
- Publication number
- JP2022535102A5 JP2022535102A5 JP2021571915A JP2021571915A JP2022535102A5 JP 2022535102 A5 JP2022535102 A5 JP 2022535102A5 JP 2021571915 A JP2021571915 A JP 2021571915A JP 2021571915 A JP2021571915 A JP 2021571915A JP 2022535102 A5 JP2022535102 A5 JP 2022535102A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- cancer
- polynucleotide
- composition
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025170954A JP2026010046A (ja) | 2019-06-05 | 2025-10-09 | Ｔｇｆ－ベータワクチン |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1908012.6 | 2019-06-05 | ||
| GBGB1908012.6A GB201908012D0 (en) | 2019-06-05 | 2019-06-05 | TGF-Beta vaccine |
| PCT/EP2020/065472 WO2020245264A1 (en) | 2019-06-05 | 2020-06-04 | Tgf-beta vaccine |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025170954A Division JP2026010046A (ja) | 2019-06-05 | 2025-10-09 | Ｔｇｆ－ベータワクチン |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022535102A JP2022535102A (ja) | 2022-08-04 |
| JP2022535102A5 true JP2022535102A5 (enExample) | 2023-06-14 |
| JP7758573B2 JP7758573B2 (ja) | 2025-10-22 |
Family
ID=67385796
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021571915A Active JP7758573B2 (ja) | 2019-06-05 | 2020-06-04 | Ｔｇｆ－ベータワクチン |
| JP2025170954A Pending JP2026010046A (ja) | 2019-06-05 | 2025-10-09 | Ｔｇｆ－ベータワクチン |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025170954A Pending JP2026010046A (ja) | 2019-06-05 | 2025-10-09 | Ｔｇｆ－ベータワクチン |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20220315634A1 (enExample) |
| EP (1) | EP3980449A1 (enExample) |
| JP (2) | JP7758573B2 (enExample) |
| KR (1) | KR20220018566A (enExample) |
| CN (1) | CN113966342B (enExample) |
| AU (2) | AU2020287902B9 (enExample) |
| CA (1) | CA3141744A1 (enExample) |
| GB (1) | GB201908012D0 (enExample) |
| IL (1) | IL288673A (enExample) |
| MX (1) | MX2021014856A (enExample) |
| SG (1) | SG11202112416XA (enExample) |
| WO (1) | WO2020245264A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4269429A4 (en) * | 2020-12-23 | 2025-07-30 | Korea Inst Sci & Tech | NEW PEPTIDE CAPABLE OF INHIBITING TGF-BETA SIGNALING AND ITS UTILIZATION |
| US20250327041A1 (en) | 2022-02-24 | 2025-10-23 | Io Biotech Aps | Nucleotide delivery of cancer therapy |
| JPWO2023224096A1 (enExample) * | 2022-05-18 | 2023-11-23 | ||
| GB202215997D0 (en) | 2022-10-28 | 2022-12-14 | Io Biotech Aps | Therapy |
| GB202216449D0 (en) | 2022-11-04 | 2022-12-21 | Io Biotech Aps | TGF-BETA1 vaccine |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US58767A (en) | 1866-10-16 | John brougjbton | ||
| US5554372A (en) | 1986-09-22 | 1996-09-10 | Emory University | Methods and vaccines comprising surface-active copolymers |
| EP0877031A1 (en) * | 1997-05-06 | 1998-11-11 | Instituut Voor Dierhouderij En Diergezondheid (Id-Dlo) | TGF-Beta1 derived peptides mimicking the activity of transforming growth factor-Beta1 |
| CA2259956A1 (en) | 1997-05-12 | 1998-11-19 | Kyowa Hakko Kogyo Co., Ltd. | Peptides promoting the activation of latent tgf-.beta. and method for screening tgf-.beta. activity regulators |
| US6500920B1 (en) * | 1997-06-19 | 2002-12-31 | St. Louis University | Inhibitor of transforming growth factor β and A method of inhibiting the biological effects of transforming growth factor |
| AU2001246393A1 (en) * | 2000-03-31 | 2001-10-08 | Vaccine Chip Technology Aps | Immunostimulating properties of a fragment of tgf-beta |
| US8158589B2 (en) * | 2003-08-22 | 2012-04-17 | Proyecto Biomedicine Cima, S.L. | Peptides with the capacity to bind to transforming growth factor β1 (TGF-β1) |
| JPWO2005105144A1 (ja) * | 2004-04-30 | 2007-09-13 | 協和醗酵工業株式会社 | 潜在型ＴＧＦ−βの活性化抑制剤 |
| EP1974740A4 (en) * | 2005-10-24 | 2010-09-01 | Proyecto Biomedicina Cima Sl | USE OF TGF-BETA1 INHIBITORY PEPTIDES IN THE PREPARATION OF AN IMMUNE RESPONSE MODULATING AGENT |
| WO2009117597A1 (en) | 2008-03-21 | 2009-09-24 | The Brigham And Women's Hospital, Inc. | Modulation of the immune response |
| US8476246B2 (en) | 2009-07-30 | 2013-07-02 | Antisense Pharma Gmbh | Combination of a chemotherapeutic agent and an inhibitor of the TGF-beta system |
| CN103087173B (zh) * | 2013-01-16 | 2014-07-16 | 西安交通大学医学院第一附属医院 | 基于TGF-β1的B细胞抗原表位的合成肽疫苗及其应用 |
| RS61778B1 (sr) * | 2013-05-06 | 2021-06-30 | Scholar Rock Inc | Kompozicije i postupci za modulaciju faktora rasta |
| AU2015229381B2 (en) * | 2014-03-11 | 2019-11-07 | University Of Florida Research Foundation, Inc. | Use of AAV-expressed M013 protein as an anti-inflammatory therapeutic |
-
2019
- 2019-06-05 GB GBGB1908012.6A patent/GB201908012D0/en not_active Ceased
-
2020
- 2020-06-04 AU AU2020287902A patent/AU2020287902B9/en active Active
- 2020-06-04 SG SG11202112416XA patent/SG11202112416XA/en unknown
- 2020-06-04 JP JP2021571915A patent/JP7758573B2/ja active Active
- 2020-06-04 WO PCT/EP2020/065472 patent/WO2020245264A1/en not_active Ceased
- 2020-06-04 EP EP20731430.3A patent/EP3980449A1/en active Pending
- 2020-06-04 CA CA3141744A patent/CA3141744A1/en active Pending
- 2020-06-04 MX MX2021014856A patent/MX2021014856A/es unknown
- 2020-06-04 US US17/616,382 patent/US20220315634A1/en active Pending
- 2020-06-04 CN CN202080040978.4A patent/CN113966342B/zh active Active
- 2020-06-04 KR KR1020227000403A patent/KR20220018566A/ko active Pending
-
2021
- 2021-12-05 IL IL288673A patent/IL288673A/en unknown
-
2025
- 2025-10-09 JP JP2025170954A patent/JP2026010046A/ja active Pending
-
2026
- 2026-01-16 AU AU2026200314A patent/AU2026200314A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022535102A5 (enExample) | ||
| US7871816B2 (en) | Vector for anti-HPV vaccine and transformed microorganism by the vector | |
| RU2007119319A (ru) | Наборы антигенов полипептида, угнетающего секрецию желудка (gip), и их применение | |
| EA016818B1 (ru) | Слитые белки, содержащие антигены отторжения опухоли ny-eso-1 и lage-1 | |
| JP2022507373A5 (enExample) | ||
| JP2024513559A5 (enExample) | ||
| CN117987471A (zh) | 一种重组病毒载体、包含其的免疫组合物以及用途 | |
| CA2432971A1 (en) | Polypeptides | |
| CA2106093A1 (en) | Recombinant anticoccidial vaccine | |
| JP2022501046A5 (enExample) | ||
| JP2006525787A (ja) | アカゲザルＨＥＲ２／ｎｅｕ、これをコードするヌクレオチド及びその使用 | |
| US8207141B2 (en) | Plasmids coding for p185neu protein sequence variants and therapeutic uses thereof | |
| JP2009520472A (ja) | 腫瘍抗原由来最適化潜在性ペプチドで構成される免疫原性ポリペプチド及びその使用 | |
| JP2003522195A (ja) | 肝細胞癌の治療のための方法及び組成物 | |
| CN102772795B (zh) | 布鲁氏菌鞭毛蛋白bmeii1112在制备布鲁氏菌亚单位疫苗中的应用 | |
| JP4459060B2 (ja) | ポリヌクレオチドからなるワクチン | |
| CN101302524A (zh) | 弓形虫多表位基因与霍乱毒素ctxa2/b亚基的融合基因及应用 | |
| JP2002510496A (ja) | 細胞傷害性ｔ細胞を誘導するための医薬 | |
| RU2005101744A (ru) | Последовательность днк и получение аллергена пыльцы трав ph1 p4 с помощью рекомбинантных способов | |
| JPWO2007018198A1 (ja) | Ｈｌａ−ａ２陽性者用ｈｓｐ１０５由来癌拒絶抗原ペプチド及びこれを含む医薬 | |
| CN102838679A (zh) | Her2-neu抗原阳性肿瘤治疗性疫苗的制备及应用 | |
| Milani et al. | HSP roles as biomarkers and antigens in bacterial and viral infections | |
| CN104736169B (zh) | 海产鱼的类结节病用dna疫苗 | |
| TWI670280B (zh) | 人類乳突病毒之脂質抗原及用於人類乳突病毒相關疾病之免疫治療組合物 | |
| JP2023520990A5 (enExample) |